A Comprehensive Review on Accurate Mesothelioma Classification Using Medical Imaging and AI Techniques

Authors

  • Shivani Jaiswal Research Scholar, Department of Computer Engineering, Sigma University, Vadodara, Gujarat, India Author
  • Dr. Sheshang Degadwala Professor & Head, Department of Computer Engineering, Sigma University, Vadodara, Gujarat, India Author
  • Vidya Vijayan Assistant Professor, Department of Computer Engineering, Sigma University, Vadodara, Gujarat, India Author

DOI:

https://doi.org/10.32628/IJSRST26134

Keywords:

Mesothelioma classification, CT imaging, Histopathological images, Artificial intelligence, Deep learning

Abstract

Mesothelioma is a rare and aggressive malignancy primarily associated with asbestos exposure, and its early diagnosis remains challenging due to subtle visual differences and overlapping clinical features. Medical imaging modalities, particularly computed tomography (CT), play a vital role in identifying pleural thickening, effusions, and tumor spread, while histopathological images provide cellular-level evidence essential for definitive diagnosis. In recent years, artificial intelligence (AI) techniques have demonstrated significant potential in enhancing the accuracy and consistency of mesothelioma classification using both CT and histopathological data. This comprehensive review analyzes existing research on mesothelioma classification employing medical imaging and AI-based approaches. It covers conventional image processing methods, machine learning techniques, and advanced deep learning models applied to CT scans and histopathological images. The review highlights the importance of feature extraction, multimodal data fusion, and robust preprocessing strategies for improving diagnostic performance. Additionally, the role of explainable AI is discussed to address clinical interpretability and trust in automated systems. Comparative performance analysis, commonly used datasets, and evaluation metrics are summarized to identify current trends, limitations, and research gaps. Finally, challenges such as data scarcity, class imbalance, and real-world clinical deployment are discussed, providing directions for future research toward reliable AI-assisted mesothelioma diagnosis.

Downloads

Download data is not yet available.

References

S. Aydın, M. Ağar, M. Çakmak, and M. Toğaçar, “Diagnosis of Mesothelioma Using Image Segmentation and Class-Based Deep Feature Transformations,” Diagnostics, vol. 15, no. 18, pp. 1–27, 2025, doi: 10.3390/diagnostics15182381. DOI: https://doi.org/10.3390/diagnostics15182381

J. Liu et al., “A novel mesothelioma molecular classification based on malignant cell differentiation,” Cancer Cell International , vol. 25, no. 1, 2025, doi: 10.1186/s12935-025-03816-9. DOI: https://doi.org/10.1186/s12935-025-03816-9

Z. Liu, J. Cai, Y. Li, and W. Weng, “External validation of pathological T adjustments in the ninth edition of the pleural mesothelioma tumor-node-metastasis classification,” Frontiers in Oncology, vol. 15, no. September, pp. 1–9, 2025, doi: 10.3389/fonc.2025.1557097. DOI: https://doi.org/10.3389/fonc.2025.1557097

G. L. Ceresoli, L. Mannarino, L. Paracchini, and F. Grosso, “Pleural mesothelioma: Long-term progression-free survival with Tumor Treating Fields (TTFields) therapy case reports,” Current Problems in Cancer: Case Reports, vol. 17, no. November 2024, pp. 4–7, 2025, doi: 10.1016/j.cpccr.2024.100342. DOI: https://doi.org/10.1016/j.cpccr.2024.100342

E. Baratella et al., “Prognostic Value of Chest CT Volumetric Analysis in Patients with Malignant Pleural Mesothelioma,” Journal of Clinical Medicine, vol. 14, no. 5, pp. 1–14, 2025, doi: 10.3390/jcm14051547. DOI: https://doi.org/10.3390/jcm14051547

Y. J. Hong et al., “Deep learning-based classification of pleural malignancy using medical thoracoscopic images,” Translational Lung Cancer Research, vol. 14, no. 10, pp. 4475–4484, 2025, doi: 10.21037/tlcr-2025-588. DOI: https://doi.org/10.21037/tlcr-2025-588

A. Aujayeb and P. Astoul, “A Diagnostic Approach to Malignant Pleural Mesothelioma,” Pulmonary Therapy, vol. 11, no. 3, pp. 503–517, 2025, doi: 10.1007/s41030-025-00301-6. DOI: https://doi.org/10.1007/s41030-025-00301-6

S. K. Agrawal, I. P. Dubey, A. K. Nair, A. Jain, A. Mahato, and R. Kumar, “Neuroimaging informatics framework for analyzing rare brain metastasis patterns in pleural mesothelioma using hybrid PET CT,” Neuroscience Informatics, vol. 5, no. 2, p. 100207, 2025, doi: 10.1016/j.neuri.2025.100207. DOI: https://doi.org/10.1016/j.neuri.2025.100207

M. Ram et al., “Predicting Mesothelioma Using Artificial Intelligence: A Scoping Review of Common Models and Applications,” Technology in Cancer Research and Treatment, vol. 24, 2025, doi: 10.1177/15330338251341053. DOI: https://doi.org/10.1177/15330338251341053

G. A. Lynch, N. A. Maskell, and A. Bibby, “Recent Advances in Mesothelioma,” Current Pulmonology Reports, vol. 13, no. 3, pp. 256–265, 2024, doi: 10.1007/s13665-024-00357-w. DOI: https://doi.org/10.1007/s13665-024-00357-w

M. Eastwood et al., “Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology data,” Artificial Intelligence in Medicine, vol. 143, no. January, p. 102628, 2023, doi: 10.1016/j.artmed.2023.102628. DOI: https://doi.org/10.1016/j.artmed.2023.102628

M. G. Mastromarino, V. Aprile, and M. Lucchi, “Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms,” Frontiers in Oncology, vol. 13, no. February, pp. 1–3, 2023, doi: 10.3389/fonc.2023.1158416. DOI: https://doi.org/10.3389/fonc.2023.1158416

J. Huang et al., “Global Incidence, Risk Factors, and Temporal Trends of Mesothelioma: A Population-Based Study,” Journal of Thoracic Oncology, vol. 18, no. 6, pp. 792–802, 2023, doi: 10.1016/j.jtho.2023.01.095. DOI: https://doi.org/10.1016/j.jtho.2023.01.095

J. Moro et al., “Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma,” Diagnostics, vol. 12, no. 12, 2022, doi: 10.3390/diagnostics12123009. DOI: https://doi.org/10.3390/diagnostics12123009

R. Shah, L. V. Klotz, and J. Glade, “Current Management and Future Perspective in Pleural Mesothelioma,” Cancers, vol. 14, no. 4, pp. 1–21, 2022, doi: 10.3390/cancers14041044. DOI: https://doi.org/10.3390/cancers14041044

M. Lapidot, E. Mazzola, and R. Bueno, “Outcomes of pleurectomy decortication in patients with biphasic mesothelioma,” Journal of Thoracic and Cardiovascular Surgery, vol. 164, no. 5, pp. 1340-1348.e3, 2022, doi: 10.1016/j.jtcvs.2022.01.054. DOI: https://doi.org/10.1016/j.jtcvs.2022.01.054

D. Štrbac and V. Dolžan, “Novel and Future Treatment Options in Mesothelioma: A Systematic Review,” International Journal of Molecular Sciences, vol. 23, no. 4, 2022, doi: 10.3390/ijms23041975. DOI: https://doi.org/10.3390/ijms23041975

J. R. Farkas, M. Sharobim, and J. J. Schulte, “Updates on the pathologic diagnosis and classification of mesothelioma,” Journal of Cancer Metastasis and Treatment, vol. 8, 2022, doi: 10.20517/2394-4722.2022.89. DOI: https://doi.org/10.20517/2394-4722.2022.89

M. G. Mastromarino et al., “New Insights in Pleural Mesothelioma Classification Update: Diagnostic Traps and Prognostic Implications,” Diagnostics, vol. 12, no. 12, pp. 1–14, 2022, doi: 10.3390/diagnostics12122905. DOI: https://doi.org/10.3390/diagnostics12122905

S. Dacic, “Pleural mesothelioma classification—update and challenges,” Modern Pathology, vol. 35, no. July 2021, pp. 51–56, 2022, doi: 10.1038/s41379-021-00895-7. DOI: https://doi.org/10.1038/s41379-021-00895-7

E. Carelli, “XCaMeL Dataset,” Kaggle, 2024. [Online]. Available: https://www.kaggle.com/datasets/emanuelecarelli/xcamel-dataset. [Accessed: Dec. 28, 2025].

Downloads

Published

06-01-2026

Issue

Section

Research Articles

How to Cite

[1]
Shivani Jaiswal, Dr. Sheshang Degadwala, and Vidya Vijayan, Trans., “A Comprehensive Review on Accurate Mesothelioma Classification Using Medical Imaging and AI Techniques”, Int J Sci Res Sci & Technol, vol. 13, no. 1, pp. 32–39, Jan. 2026, doi: 10.32628/IJSRST26134.